Vera Therapeutics, Inc.
VERADrugs in Pipeline
2
Phase 3 Programs
1
Upcoming Catalysts
1
Next Catalyst
Next month
Market Overview
Stock performance and key metrics
2 upcoming, 2 past
How VERA's past catalysts played out
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Full breakdown — the signals behind the verdict
Frequently asked questions
What is in Vera Therapeutics, Inc.'s drug pipeline?→
CatalystAlert tracks 2 drug candidates in Vera Therapeutics, Inc.'s (VERA) pipeline across Phase 3, Phase 2. Its lead program is Atacicept (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Vera Therapeutics, Inc.'s next FDA catalyst?→
Vera Therapeutics, Inc.'s (VERA) next tracked catalyst is a Earnings expected August 4, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track VERA biotech catalysts?→
Add VERA to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Vera Therapeutics, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.